Business
Currency:CNY
2024/FY
Stock NameRevenueRatio
出售自体嵌合抗原受体T细胞免疫治疗产品所得收入158.22M100.00%
Product
Currency:CNY
2024/FY
Stock NameRevenueRatio
倍诺达158.22M100.00%
Region
No Data